Tangeretin inhibits streptozotocin‐induced cell apoptosis via regulating NF‐κB pathway in INS‐1 cells

摘要

Abstract Oxidative stress is considered to play an important role in inducing the pancreatic β‐cells apoptosis and promoting the development of diabetes mellitus. Tangeretin is a plant‐derived flavonoid that retains antidiabetic effects. However, the role of tangeretin in streptozotocin (STZ)‐induced β‐cell apoptosis remains unclear. In this study, we aimed to examine the effects of tangeretin on STZ‐induced cell apoptosis and the underlying mechanisms implicated in vitro. Our results showed that tangeretin improved the cell viability in STZ‐induced INS‐1 cells. Tangeretin reduced the increase of apoptosis ratio and revered the altered expressions of Bax and Bcl‐2 caused by STZ induction. Furthermore, the impairment of insulin secretion ability as well as a reduction in messenger RNA levels of insulin 1 and 2 was significantly attenuated by tangeretin in STZ‐induced INS‐1 cells. Moreover, tangeretin resulted in a significant decrease in reactive oxygen species content, accompanied by an evident increase in the activities of superoxide dismutase, catalase, and glutathione peroxidase. Mechanistic studies further revealed that tangeretin inhibited the NF‐κB pathway in STZ‐induced INS‐1 cells. These data indicated that tangeretin improved the cell apoptosis induced by STZ in INS‐1 cells, which might be partly due to its antioxidant potential. Furthermore, NF‐κB was found to be involved in the protective effect of tangeretin. Collectively, the results indicated that tangeretin could be used as a therapeutic approach for diabetes mellitus treatment.